Why the study?
What is the contemporary burden and prevalence of symptomatic PSVT among US adults?
What is the contemporary burden and prevalence of symptomatic PSVT among US adults?
Symptomatic PSVT affects at least 0.168% of US adults, and specific diagnostic codes in inpatient and ED settings can help identify these episodes and high-risk individuals.
Projected 0.168% symptomatic PSVT prevalence informs clinician awareness; leaves open prospective validation of diagnostic code identification.
Selected diagnostic codes in inpatient and emergency department settings may be useful to identify symptomatic PSVT episodes. We project that at least 0.168% of US adults experience symptomatic PSVT, and certain characteristics can identify people at higher risk.
No takes yet. Share an insight, caveat, or question.
Go et al. (2018) studied this question.
Synapse has enriched 5 related papers. Consider them for comparative context: